Use of bone mesenchymal stem cells to treat rats with acute liver failure

S.F. Yuan, T. Jiang, L.H. Sun, R.J. Zheng, G.Q. Cao, N.Z. Ahat, Y.X. Zhang
2014 Genetics and Molecular Research  
Stem cells and acute liver failure transplantation group after 120 and 168 h of transplantation (P < 0.05). Histological data revealed that hepatocyte cell apoptosis was lower in the transplantation group compared to the control groups (P < 0.05), and that the transplantation of BMSCs reduced liver inflammation, decreased hepatic denaturation and necrosis, and promoted liver regeneration. These ameliorations were not recorded in the control groups. The results of in situ hybridization,
more » ... orescence staining, and Western blot confirmed the presence of transplanted BMSCs in recipient rat livers. Stromal cell derived factor-1 alpha and vascular endothelial growth factor were significantly upregulated after the intraportal transplantation of BMSCs, with significantly higher levels being found in the portal vein and the tail vein groups (P < 0.05). In conclusion, BMSCs have a therapeutic effect against ALF rats, evoke endogenous repair mechanisms in the liver, and may represent a novel form of therapeutic intervention for the disease. Furthermore, intraportal transplantation serves as a more effective pathway compared to tail vein transplantation.
doi:10.4238/2014.april.30.10 pmid:24841910 fatcat:wcwcu4gsgrcjlaz4qamxfjplkm